EPIDAUROS Biotechnologie

EPIDAUROS Biotechnologie was a pioneering German pharmacogenetics company focused on improving drug safety and efficacy through genetic biomarker discovery. Founded in 1997 and headquartered in Bernried, the company specialized in identifying variations in genes encoding drug transporters and metabolizing enzymes, such as CYP2D6 and MDR1. EPIDAUROS operated as a Pharmacogenetic Research Organization (PRO), providing genotyping services and consultancy to the global pharmaceutical industry. The company established a significant intellectual property portfolio of clinically validated genetic markers, which were licensed to major diagnostic partners like Roche and Luminex. In 2007, EPIDAUROS was acquired by Clinical Data, Inc. to bolster its personalized medicine and pharmacogenomics capabilities.